Myrtilene forte capsules 177mg, No. 20

• Moderate to high myopia;

• acquired hemeralopia;

• diabetic retinopathy;

• violation of the mechanisms of adaptation of vision to darkness (with night and twilight vision);

• muscle asthenopia;

• central atherosclerotic retinal degeneration of the Kunt-Junius type;

• tapetoretinal retinal abiotrophy (retinal pigment degeneration).

The drug is administered orally, 1 capsule 3 times / day. The course of treatment is 1 month.

Capsules are soft gelatinous, oval, dark brown with a slightly shiny smooth surface.

1 caps.

dry extract of common blueberries (76-153: 1) 177 mg

incl. anthocyanidins 25%

Excipients: soybean oil, hydrogenated vegetable oil.

Individual hypersensitivity to the active substance of the drug or to any auxiliary ingredients included in its composition.

pharmachologic effect

A drug that improves the functional state of the retina for systemic use. Bilberry anthocyanosodes (Vaccinium myrtilus) stimulate the synthesis and regeneration of rhodopsin (retinal light-sensitive pigment), increasing its sensitivity to changes in light intensity. Improves visual acuity and adaptation to darkness in low light conditions. Helps to improve blood supply to the retina.

Side effect

Possible: allergic reactions.

Application during pregnancy and lactation

Currently, there is no reliable data on the use of the drug Mirtilene Forte during pregnancy and lactation (breastfeeding). Therefore, the drug should be used in these categories of patients only if the expected benefit outweighs the potential risk.

Application in children

Currently, there is no reliable data on the use of the drug Mirtilene forte in children. Therefore, the drug should be used in this category of patients only if the expected benefit outweighs the potential risk.

special instructions

Currently, there is no reliable data on the use of the drug Mirtilene forte in children. Therefore, the drug should be used in this category of patients only if the expected benefit outweighs the potential risk.

Overdose

To date, no cases of overdose of the drug Mirtilene Forte have been reported.

Drug interactions

The drug interaction of the drug Mirtilene forte has not been described.